IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Spark Therapeutics, Inc.
Symbol: ONCE
Price: Last trade $50.55
Trade Date: 12/16
Shares: 3 million
Underwriter(s) J.P. Morgan, Cowen, Evercore, SunTrust Robinson Humphrey,
Co Manager(s) Roth Capital Partners
Rating=Subscription Needed
Company: Norwegian Cruise Line Holdings Ltd.-BLOCK
Symbol: NCLH
Price: Last trade $59.46
Trade Date: 12/15
Shares: 10.3 million
Underwriter(s) Goldman Sachs
Rating=Subscription Needed
Company: Dave & Busters-BLOCK
Symbol: PLAY
Price: Last trade $39.41
Trade Date: 12/15
Shares: 2.5 million
Underwriter(s) Jefferies
Rating=Subscription Needed